Drug intelligence / Profile preview

Kee7

Development stage: Unknown
Lead developer: Kee Pharma
Modality: Small Molecules
Administration: Oral

Overview

Kee7 is an antioxidant-rich nutraceutical supplement developed and manufactured by Kee Pharma Limited. It is administered orally as a soft gel capsule and contains a combination of seven key ingredients: lycopene, green tea extract, beta carotene (Vitamin A), wheat germ oil (Vitamin E), calcium ascorbate (Vitamin C), selenium, and zinc. The product is designed to combat oxidative stress and is marketed for the management of oral submucous fibrosis (OSMF), pre-eclampsia, intrauterine growth restriction (IUGR), male infertility, and general debility. As a nutraceutical, its therapeutic effects are derived from the collective antioxidant and nutritional properties of its constituent vitamins and minerals.

Brand names: Kee7Kee-7Kee 7

Targets

AR (Adrenergic receptors)

Beyond the preview

Go deeper on Kee7.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kee7.

Explore the full profile